We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+1.55%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.29B
AUM Growth
-$122M
Cap. Flow
-$104M
Cap. Flow %
-8.05%
Top 10 Hldgs %
31.67%
Holding
282
New
11
Increased
30
Reduced
43
Closed
37

Sector Composition

Rank Sector Weight
1 Financials 34.2%
2 Healthcare 21.4%
3 Consumer Discretionary 9.38%
4 Industrials 6.44%
5 Communication Services 5.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DTI icon
101
Drilling Tools International
DTI
$81.2M
$1.5M 0.12%
150,000
BZAI
102
Blaize Holdings
BZAI
$133M
$1.5M 0.12%
150,000
AKIC
103
DELISTED
Sports Ventures Acquisition Corp. Class A Ordinary Shares
AKIC
$1.49M 0.12%
150,000
-50,000
-25% -$495K
AGCB
104
DELISTED
Altimeter Growth Corp 2
AGCB
$1.49M 0.11%
150,000
CMPR icon
105
Cimpress
CMPR
$2.44B
$1.45M 0.11%
59,300
+41,800
+239% +$1.43M
ACQR
106
DELISTED
Independence Holdings Corp. Class A Ordinary Share
ACQR
$1.39M 0.11%
140,000
IMTXW
107
DELISTED
Immatics N.V. Warrants
IMTXW
$1.35M 0.1%
500,000
JMAC
108
DELISTED
Maxpro Capital Acquisition Corp. Class A Common Stock
JMAC
$1.31M 0.1%
130,000
LIBY
109
DELISTED
Liberty Resources Acquisition Corp. Class A Common Stock
LIBY
$1.26M 0.1%
125,000
DAOO
110
DELISTED
Crypto 1 Acquisition Corp Class A Ordinary Shares
DAOO
$1.25M 0.1%
125,000
DEVS
111
DELISTED
DevvStream Corp
DEVS
$1.25M 0.1%
12,490
-12,510
-50% -$1.25M
CRESW
112
DELISTED
Cresud SACIF y A. Warrant
CRESW
$1.17M 0.09%
2,734,210
LRMR icon
113
Larimar Therapeutics
LRMR
$426M
$1.14M 0.09%
354,928
+106,128
+43% +$266K
UBX
114
DELISTED
Unity Biotechnology
UBX
$1.11M 0.09%
+282,245
New +$1.78M
FRLA
115
DELISTED
Fortune Rise Acquisition Corporation Class A Common Stock
FRLA
$1.02M 0.08%
100,000
WEL
116
DELISTED
Integrated Wellness Acquisition Corp
WEL
$1.01M 0.08%
100,000
VSAC
117
DELISTED
Vision Sensing Acquisition Corp. Class A Common Stock
VSAC
$1.01M 0.08%
100,000
ROCL
118
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
$998K 0.08%
100,000
AOGO
119
DELISTED
Arogo Capital Acquisition Corp. Class A Common Stock
AOGO
$994K 0.08%
100,000
ATAQ
120
DELISTED
Altimar Acquisition Corp III
ATAQ
$993K 0.08%
100,000
ARDX icon
121
Ardelyx
ARDX
$1.21B
$951K 0.07%
798,405
KD icon
122
Kyndryl
KD
$3.07B
$828K 0.06%
+100,000
New +$1.04M
GTI
123
DELISTED
Graphjet Technology
GTI
$761K 0.06%
1,250
PCX
124
DELISTED
Parsec Capital Acquisitions Corp Class A Common Stock
PCX
$759K 0.06%
75,000
BRG
125
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$728K 0.06%
27,212

Similar funds

683 Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, 683 Capital Management held 282 positions worth $1.29B, down 8.6% from $1.42B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

683 Capital Management withdrew a net $104M in Q3 2022, closing 37 positions and reducing 43 holdings. Its most notable exit was General Motors, an estimated $44.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, 683 Capital Management opened a new position in Builders FirstSource worth $23M.

  • 683 Capital Management's largest Q3 2022 buy was Builders FirstSource: 390,000 shares worth $23M.
  • 683 Capital Management added most to Capital One in Q3 2022, an estimated $13.8M increase.
  • 683 Capital Management's biggest Q3 2022 reduction was Syndax Pharmaceuticals, cutting an estimated $10.1M.
  • 683 Capital Management fully exited General Motors in Q3 2022, selling an estimated $44.2M.
  • 683 Capital Management's ten largest holdings make up 32% of its $1.29B portfolio in Q3 2022.
  • 683 Capital Management opened 11 new positions and closed 37 in Q3 2022.
  • 683 Capital Management's portfolio value fell 8.6% quarter-over-quarter to $1.29B.

Based on 683 Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.